Sponsor Pipeline

Tokyo Women's Medical University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Phase 3
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-04 NCT07562178
Pemafibrate for Symptomatic ICAS RCT		 Trial sites expanded: 19 -> 37 locations
Active Trials by Phase
Phase 3
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07671885 Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize… Breast Cancer Recruiting
Not specified
NCT07066358 Simultaneous Bilateral Radiofrequency Thalamotomy for Medication-Refractory Essential… Essential Tremor Recruiting
NCT07562178 Pemafibrate for Symptomatic ICAS RCT Intracranial Atherosclerotic Disease (ICAD) Recruiting
Disease Areas
Stroke (1) Breast Cancer (1)
Get alerts when Tokyo Women's Medical University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free